Oraibi Omar
Department of Internal Medicine, Jazan University, Jazan, SAU.
Cureus. 2024 Jul 18;16(7):e64828. doi: 10.7759/cureus.64828. eCollection 2024 Jul.
Cannabinoid hyperemesis syndrome (CHS) pathophysiology remains largely unknown, and it is often misdiagnosed. This paper identifies the clinical causes of CHS, outlines diagnostic and therapeutic approaches, and emphasizes early detection, comprehensive treatment, and timely intervention for improved patient outcomes. This case describes a 38-year-old male with a known history of cannabis use who experienced repeated episodes of intense vomiting, nausea, and abdominal pain consistent with symptoms of CHS. He was initially misdiagnosed with other gastrointestinal conditions despite the knowledge of marijuana ingestion. The diagnosis of CHS was initially missed; however, after further examination and consideration of his marijuana use, CHS was correctly identified. The patient's symptoms improved after the cessation of marijuana use. This case illustrates the diagnostic difficulties of cannabinoid hyperemesis syndrome (CHS) in cannabis users with significant gastrointestinal symptoms. The early detection and cessation of marijuana use are crucial for symptom management and resolution, emphasizing clinical awareness and personalized treatment.
大麻素呕吐综合征（CHS）的病理生理学在很大程度上仍然未知，且常被误诊。本文确定了CHS的临床病因，概述了诊断和治疗方法，并强调早期发现、综合治疗和及时干预以改善患者预后。本病例描述了一名38岁男性，有大麻使用史，经历了与CHS症状相符的反复剧烈呕吐、恶心和腹痛发作。尽管知道他吸食大麻，但他最初被误诊为其他胃肠道疾病。CHS的诊断最初被漏诊；然而，经过进一步检查并考虑到他使用大麻的情况后，CHS被正确识别。停止使用大麻后，患者的症状有所改善。本病例说明了在有明显胃肠道症状的大麻使用者中诊断大麻素呕吐综合征（CHS）的困难。早期发现并停止使用大麻对于症状管理和缓解至关重要，强调了临床意识和个性化治疗。
